Literature DB >> 20006698

Acrylamide catalytically inhibits topoisomerase II in V79 cells.

Giulia Sciandrello1, Maurizio Mauro, Fabio Caradonna, Irene Catanzaro, Marghereth Saverini, Giusi Barbata.   

Abstract

The vinyl monomer acrylamide is characterized by the presence of an alpha,beta-unsaturated carbonyl group that makes it reactive towards thiol, hydroxyl or amino groups and towards the nucleophilic centers in DNA. The ability of acrylamide to chemically modify protein thiols has prompted us to consider topoisomerase II as one possible target of acrylamide, since agents targeting protein sulfhydryl groups act as either catalytic inhibitors or poisons of topoisomerase II. Nuclear extracts from V79 Chinese hamster cells incubated with acrylamide reduced topoisomerase II activity as inferred by an inability to convert kinetoplast DNA to the decatenated form. Nuclear extracts incubated with acrylamide pre-incubated with DTT converted kinetoplast DNA to the decatenated form, suggesting that acrylamide influences topoisomerase II activity through reaction with sulfhydryl groups on the enzyme. Furthermore, acrylamide did not induce the pBR322 DNA cleavage, as assessed by cleavage assay; thus, it cannot be regarded as a poison of topoisomerase II. As a catalytic inhibitor, acrylamide antagonizes the effect of etoposide, a topoisomerase II poison, as determined by clonogenic assay in V79 cells. This antagonism is confirmed by band depletion assay, from which it can be inferred that acrylamide reduces the level of catalytically active cellular topoisomerase II available for the action of etoposide. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006698     DOI: 10.1016/j.tiv.2009.12.010

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II.

Authors:  Xia Xue; Xian-Jun Qu; Zu-Hua Gao; Cui-Cui Sun; Hui-Ping Liu; Cui-Rong Zhao; Yan-Na Cheng; Hong-Xiang Lou
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

2.  Cadmium is a catalytic inhibitor of DNA topoisomerase II.

Authors:  Xing Wu; Jack C Yalowich; Brian B Hasinoff
Journal:  J Inorg Biochem       Date:  2011-02-26       Impact factor: 4.155

3.  Methylation of cytokines gene promoters in IL-1β-treated human intestinal epithelial cells.

Authors:  Fabio Caradonna; Ilenia Cruciata; Ilaria Schifano; Chiara La Rosa; Flores Naselli; Roberto Chiarelli; Anna Perrone; Carla Gentile
Journal:  Inflamm Res       Date:  2017-12-18       Impact factor: 4.575

4.  Genotoxicity and Epigenotoxicity of Carbazole-Derived Molecules on MCF-7 Breast Cancer Cells.

Authors:  Claudio Luparello; Ilenia Cruciata; Andreas C Joerger; Cory A Ocasio; Rhiannon Jones; Raysa Khan Tareque; Mark C Bagley; John Spencer; Martin Walker; Carol Austin; Tiziana Ferrara; Pietro D Oca; Rossella Bellina; Rossella Branni; Fabio Caradonna
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 6.208

Review 5.  Science and Healthy Meals in the World: Nutritional Epigenomics and Nutrigenetics of the Mediterranean Diet.

Authors:  Fabio Caradonna; Ornella Consiglio; Claudio Luparello; Carla Gentile
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.